clofibrate has been researched along with vitamin k semiquinone radical in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (69.23) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaalhus, O; Mikalsen, SO; Reith, A; Sanner, T | 1 |
| O'Reilly, RA | 3 |
| Corrigan, JJ; Marcus, FI | 1 |
| Eipe, J | 1 |
| Blatrix, C; Thebault, J; Tillement, JP | 1 |
| Mattei, C; Tillement, JP; Zini, R | 1 |
| Aggeler, PM; O'Reilly, RA | 1 |
| Fujii, J; Islam, KN; Kawata, S; Kayanoki, Y; Matsuzawa, Y; Suzuki, K; Taniguchi, N | 1 |
| Burcham, PC; Calder, IC; Nicholls-Grzemski, FA; Priestly, BG | 1 |
| Conzelmann, E; Hiltunen, JK; Ilves, M; Kotti, TJ; Savolainen, K; Savolainen, TI; Schmitz, W; Sormunen, RT; Vainio, SJ | 1 |
6 review(s) available for clofibrate and vitamin k semiquinone radical
| Article | Year |
|---|---|
Hypervitaminosis E and coagulation.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Factors; Clofibrate; Ecchymosis; Humans; Male; Middle Aged; Prothrombin Time; Vitamin E; Vitamin K; Warfarin | 1975 |
Warfarin metabolism and drug-drug interactions.
Topics: Anti-Bacterial Agents; Aspirin; Barbiturates; Cholestyramine Resin; Clofibrate; Diuretics; Drug Interactions; Ethanol; Humans; Rifampin; Vitamin K; Warfarin | 1987 |
The pharmacodynamics of the oral anticoagulant drugs.
Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Factors; Blood Proteins; Clofibrate; Coumarins; Dicumarol; Disulfiram; Ethyl Biscoumacetate; Female; Heparin; Intestinal Absorption; Liver; Phenylbutazone; Protein Binding; Prothrombin; Prothrombin Time; Rabbits; Rats; Salicylates; Sulfonamides; Vitamin K; Vitamin K Deficiency; Warfarin | 1974 |
Drugs affecting therapy with anticoagulants.
Topics: Anticoagulants; Chloramphenicol; Clofibrate; Contraceptives, Oral; Coumarins; Diuretics; Drug Interactions; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethanol; Heparin; Humans; Hypnotics and Sedatives; Phenylbutazone; Phenytoin; Salicylates; Thyroxine; Tolbutamide; Vitamin K | 1972 |
Drug interactions involving oral anticoagulants.
Topics: Animals; Anticoagulants; Barbiturates; Blood Coagulation; Blood Coagulation Factors; Cholestyramine Resin; Clofibrate; Disulfiram; Diuretics; Dogs; Drug Interactions; Heparin; Humans; In Vitro Techniques; Intestinal Absorption; Kinetics; Liver Diseases; Phenylbutazone; Protein Binding; Prothrombin Time; Rats; Receptors, Drug; Salicylates; Serum Albumin; Time Factors; Vitamin K; Vitamin K Deficiency | 1974 |
Determinants of the response to oral anticoagulant drugs in man.
Topics: Administration, Oral; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Clofibrate; Coumarins; Diuresis; Dogs; Heparin; Humans; Hypnotics and Sedatives; Liver Diseases; Metabolic Diseases; Phenylbutazone; Rats; Salicylates; Sulfonamides; Thrombosis; Uremia; Vitamin K | 1970 |
7 other study(ies) available for clofibrate and vitamin k semiquinone radical
| Article | Year |
|---|---|
Role of catalase and oxidative stress in hepatic peroxisome proliferator-induced morphological transformation of Syrian hamster embryo cells.
Topics: Amitrole; Animals; Catalase; Cell Line, Transformed; Cell Transformation, Neoplastic; Cells, Cultured; Clofibrate; Cricetinae; Diethylhexyl Phthalate; Electron Spin Resonance Spectroscopy; Fatty Alcohols; Hydrogen Peroxide; Liver; Mesocricetus; Microbodies; Vitamin K | 1990 |
Coagulopathy associated with vitamin E ingestion.
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Clofibrate; Hemorrhage; Humans; Male; Methods; Middle Aged; Prothrombin Time; Pulmonary Embolism; Sodium; Vitamin E; Vitamin K; Vitamin K Deficiency; Warfarin | 1974 |
[Drug interactions with vitamin K antagonists].
Topics: Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anticoagulants; Antineoplastic Agents; Barbiturates; Benzofurans; Clofibrate; Coumarins; Diuretics; Drug Antagonism; Drug Interactions; Drug Synergism; Humans; Hypoglycemic Agents; Monoamine Oxidase Inhibitors; Salicylates; Steroids; Sulfonamides; Thyroxine; Vitamin K; Warfarin | 1973 |
Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro.
Topics: Acenocoumarol; Anticoagulants; Binding Sites; Clofibrate; Ethyl Biscoumacetate; Humans; Phenindione; Protein Binding; Receptors, Drug; Serum Albumin; Vitamin K; Warfarin | 1974 |
The protective role of glutathione peroxidase in apoptosis induced by reactive oxygen species.
Topics: Animals; Antioxidants; Apoptosis; Benzene Derivatives; Catalase; Cattle; Cell Line; Cell Survival; Clofibrate; Glucose Oxidase; Glutathione Peroxidase; Hydrogen Peroxide; Oxidative Stress; Peroxides; Reactive Oxygen Species; Selenious Acid; Selenium; Selenium Compounds; Superoxide Dismutase; Superoxides; Vitamin K; Xanthine Oxidase | 1996 |
Pretreatment with peroxisome proliferators protects mice against some but not all hepatotoxins.
Topics: Animals; Clofibrate; Drug Administration Schedule; Hypolipidemic Agents; Liver; Male; Mice; Microbodies; Paraquat; Vitamin K | 1996 |
A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Bile Acids and Salts; Body Weight; Cholesterol; Cholesterol 24-Hydroxylase; Clofibrate; Cytochrome P-450 CYP3A; Deficiency Diseases; Deoxyribonucleases, Type II Site-Specific; Dietary Fats; Disease Models, Animal; Female; Gene Expression Regulation; Hypolipidemic Agents; Kidney; Lipids; Liver; Male; Membrane Proteins; Mice; Mice, Mutant Strains; Oxidoreductases, N-Demethylating; Phytol; Racemases and Epimerases; Steroid Hydroxylases; Vitamin K | 2004 |